The University of Oregon dedicated the first phase of the Phil and Penny Knight Campus for Accelerating Scientific Impact in December of 2020 in Eugene. Designed by Ennead Architects and Bora Architects to encourage interaction and collaboration, the $225 million, 160,000-sf building offers leading-edge biomedical laboratories, core facilities, classrooms, and an innovation center.
Alexandria Real Estate Equities has attained the world's first WELL Health-Safety Rating for laboratory space at Alexandria LaunchLabs in New York City. Augmenting the center’s existing WELL certification for building design, the WELL Health-Safety Rating for Facilities Operations and Management includes further measures to protect the health of tenants, employees, visitors, and service personnel. Protocols at Alexandria LaunchLabs include:
The Centre for Process Innovation (CPI) began construction in October of 2020 on the Medicines Manufacturing Innovation Centre in Inchinnan in the United Kingdom. Created in collaboration with the University of Strathclyde, GSK, and AstraZeneca, the £42 million facility will enable the development of new pharmaceutical production methods that will be proven at scale in a GMP environment.
Lincoln Property Company is creating a mixed-use campus in Lexington, Mass. Designed by DiMella Shaffer, the development will include a laboratory building providing 95,000 sf of Class A research space linked by a central promenade to a 125,000-sf office facility. Strategically sited in the burgeoning life sciences district along the Route 128 corridor, the complex will include a community hub with a café to encourage interaction and collaboration between tenants, as well as a 502-space parking garage.
The University of Texas at El Paso opened the $93.5 million Interdisciplinary Research Building in September of 2020. Designed by Perkins+Will, the 156,000-sf project provides collaborative research labs, a vivarium, imaging suites, core labs, a visualization suite, conference rooms, an atrium, an auditorium, and academic and administrative offices. Housing teams from multiple departments, the flexible facility can be easily adapted to accommodate changing program requirements.
Merck is constructing a $69 million facility for the production of high-potency active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) compounds. Representing an expansion of the company's existing campus near Madison, the 70,000-sf structure will feature containment environments specifically designed for the manufacture of substances with single-digit nanogram occupational exposure limits. The building will allow the large-scale production of increasingly potent compounds for the creation of innovative cancer therapeutics.
Facility Logix, EwingCole, and Biggins Lacy Shapiro have launched Rapid Reshore & Development (RR&D) to provide turnkey professional services to the life sciences and biopharmaceutical industries. Addressing many of the logistical challenges faced by companies developing drugs, vaccines, and medical devices, the alliance represents an evolution from transaction-driven service models to a holistic focus on client needs.
Construction began in October of 2020 on the $44.2 million Discovery Square 2 building in Rochester, Minn. Designed by RSP Architects, the 125,000-sf facility will offer leasable research environments for life science companies. Sited in the Destination Medical Center district, the five-story structure will feature advanced laboratory infrastructure, centralized common spaces, and a physical connection to the adjacent One Discovery Square building.
King Street Properties has fully leased a 214,440-sf research facility in Lexington, Mass., to four pharmaceutical companies. Designed by R E Dinneen Architects & Planners, the four-story building will offer leading-edge lab and office environments for biomedical research. JLL is the leasing agent for the development, which has yet to open. Tenants include:
The University of Nevada, Reno opened the $92 million William N. Pennington Engineering Building in August of 2020. Designed by H+K Architects, the 100,000-sf facility offers dedicated space for the departments of chemical and materials engineering, civil and environmental engineering, electrical and biomedical engineering, mechanical engineering, and computer science. The collaborative four-story building provides 40 labs, a 200-seat classroom, two computer labs, 40 faculty offices, and 150 graduate student workstations.
Fujifilm Diosynth Biotechnologies broke ground in August of 2020 on the $55 million Advanced Therapies Innovation Center in College Station, Texas. Representing an expansion of Fujifilm's cGMP manufacturing campus, the 60,000-sf facility will feature dedicated labs for process development and innovation. Research environments with BSL-2 capabilities will integrate advanced technologies for upstream, downstream, and analytical development.
Nagasaki University is planning to build a BSL-4 laboratory for SARS-CoV-2 research. The biocontainment facility will be located in an eight-story, 43,000-sf building providing specialized environments for the detection, study, and mitigation of infectious diseases. A dedicated area will accommodate novel coronavirus research. The Japanese government is expected to award $9.5 million in funding for fiscal year 2021 towards the construction of the project, which will also support training programs and the development of human resources.
Codiak BioSciences is constructing a 12,000-sf clinical manufacturing center in Lexington, Mass. The project includes the build-out of a leased lab and office building to create a GMP facility for the production of exosome therapeutics. Codiak is incorporating G-CON Manufacturing's PODs into the center to provide flexible cleanroom capacity. The prefabricated units offer exceptional scalability and mobility, and can be easily repurposed to meet future needs.
16 Tech Community Corporation opened the $50 million Innovation Building 1 in August of 2020 in Indianapolis. Developed by Browning, the 120,000-sf facility was constructed by Davis & Associates and is now fully leased. The Indiana Biosciences Research Institute is occupying 67,000 sf on the first three floors of the building. The five-story structure will accommodate the Central Indiana Corporate Partnership, as well as providing 12,000 sf of research space for Indiana University's Center for Regenerative Medicine.
CRISPR Therapeutics signed a full-building lease in July of 2020 for a 263,500-sf facility in Boston's Seaport district. Breakthrough Properties is the developer for the project, which was designed by Payette to provide best-in-class laboratory environments for life science research. Both LEED Gold and Fitwel certification will be sought for the structure, which will offer multiple amenities including outdoor terraces and a fitness center.
